Abstract 1811: AFVT-2101: A FRα × CD16A bispecific innate cell engager for the treatment of solid tumors

MLA

Nicolo’ Rigamonti, et al. “Abstract 1811: AFVT-2101: A FRα × CD16A Bispecific Innate Cell Engager for the Treatment of Solid Tumors.” Cancer Research, vol. 83, Apr. 2023, p. 1811. EBSCOhost, https://doi.org/10.1158/1538-7445.am2023-1811.

APA

Nicolo’ Rigamonti, Jan Schmollinger, Peter Sandy, Michael Tomaszowski, Josef Caslavsky, Ahmad Trad, Daniel O’Shannessy, Jana Siegler, Eric J. Gaukel, Daniela Penston, Uwe Reusch, & Zoë Johnson. (2023). Abstract 1811: AFVT-2101: A FRα × CD16A bispecific innate cell engager for the treatment of solid tumors. Cancer Research, 83, 1811. https://doi.org/10.1158/1538-7445.am2023-1811

Chicago

Nicolo’ Rigamonti, Jan Schmollinger, Peter Sandy, Michael Tomaszowski, Josef Caslavsky, Ahmad Trad, Daniel O’Shannessy, et al. 2023. “Abstract 1811: AFVT-2101: A FRα × CD16A Bispecific Innate Cell Engager for the Treatment of Solid Tumors.” Cancer Research 83 (April): 1811. doi:10.1158/1538-7445.am2023-1811.